Innovative Therapeutic Delivery Strategies for Brain Tumors: Overcoming Barriers and Modulating the Tumor Microenvironment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 41
Special Issue Editors
Interests: nanotechnology; biosensors; virus-like particles applications; fluorescent RNA/RNAi/drug delivery systems
Interests: brain tumor; microRNA; systemic lupus erythematosus; bioinformatics; immunity and autoimmunity
Interests: brain tumor; DIPG; telomere damage; DNA damage; radiotherapy
Interests: drug delivery; cancer immunotherapy; cardiovascular disease; pharmaceutical science
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Brain tumors remain one of the most challenging malignancies due to their complex tumor microenvironment, the presence of the blood–brain barrier, and their ability to evade immune responses. Advanced therapeutic delivery systems, including drug formulations, gene therapy, and immunotherapy, have emerged as promising strategies for enhancing treatment efficacy. This Special Issue aims to gather cutting-edge research on innovative delivery methods and their effects on the tumor microenvironment, immune responses, and surrounding tissues. We welcome the submission of original research and review articles covering novel drug delivery technologies, their mechanisms of interaction with brain tumor microenvironments, and translational and clinical findings. This collection will provide valuable insights for researchers and clinicians working toward improved therapeutic strategies for primary and metastatic brain tumors.
Dr. Hao-Han Pang
Dr. Zhuang Wang
Dr. Banlanjo A. Umaru
Dr. Lisha Liu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- drug delivery
- blood–brain barrier
- immunotherapy
- gene therapy
- tumor microenvironment
- nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
